Lupin launches cardiovascular drug in US market
Lupin : It launched generic heart rivaroxaban tablets in the US market after it received approval from the US Food and Drug Administration (US FDA). According to the company, the…
Lupin receives US FDA Establishment Inspection Report for Somerset facility
Lupin has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its manufacturing facility in Somerset, New Jersey.…
US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%
Share of pharma companies saw red on February 14 as caution over the possibility of US tariffs hitting the sector spread across the Street. This came after US President Donald…
CDSCO issues alert against 62 substandard drugs; Samples from Lupin, Jackson Laboratories flagged
The Central Drugs Standard Control Organisation (CDSCO) has flagged 62 drug samples as they failed the quality test. The alert was issued by the drug regulator for November 2023. The drug regulator’s…
Lupin launches Posaconazole Delayed-Release Tablets
Lupin announced the launch of Posaconazole Delayed-Release Tablets, 100 mg, after its alliance partner AET Pharma US (part of Tiefenbacher Group) received approval for its ANDA from the United States Food and…
Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solution
NEW DELHI: Drug firm Lupin on Thursday said it has received tentative nod from the US health regulator to market generic Efinaconazole topical solution used for treatment of fungal infections of toenails. The company has received…
Lapatinib Tablets Launched by LUPIN
Lapatinib Tablets, 250 mg, has been announced by pharma giant LUPIN after its alliance with Natco Pharma which received final approval for its ANDA from the United States Food and…
Sun Pharma Dropped In Market After Us Lawsuit
Share prices of some leading domestic pharmaceutical companies, led by Sun Pharmaceutical Industries, fell 4-9 per cent on Monday, after being named in a price-fixing lawsuit in the US. The…
1.7 LAKH BOTTLES OF TABLETS RECALLED BY LUPIN & DR. REDDY’S
New Delhi – Drug majors Lupin and Dr. Reddy’s are recalling over 1.7 lakh bottles of two different tablets, used in the treatment of blood pressure and acidity, in the…
